171 related articles for article (PubMed ID: 33045302)
21. Cationic Nanoparticle-Stabilized Vaccine Delivery System for the H9N2 Vaccine to Promote Immune Response in Chickens.
Zhang Y; Zhu T; Xu S; Gu P; Cai G; Peng S; Liu Z; Yang Y; Hu Y; Liu J; Wang D
Mol Pharm; 2023 Mar; 20(3):1613-1623. PubMed ID: 36795759
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of immune responses using ovalbumin-conjugated Eucommia ulmoides leaf polysaccharides encapsulated in a cubic liquid-crystalline phase delivery system.
Feng H; Zhang L; Yang J; Li S; Tang F; Li H; Zhang X; Wu D; Feng Y; Liu Q; Liu Z
J Sci Food Agric; 2022 Nov; 102(14):6757-6770. PubMed ID: 35638143
[TBL] [Abstract][Full Text] [Related]
23. In Vitro Evaluation of the Biological Responses of Canine Macrophages Challenged with PLGA Nanoparticles Containing Monophosphoryl Lipid A.
Guldner D; Hwang JK; Cardieri MC; Eren M; Ziaei P; Norton MG; Souza CD
PLoS One; 2016; 11(11):e0165477. PubMed ID: 27835636
[TBL] [Abstract][Full Text] [Related]
24. A nanovaccine formulation of Chlamydia recombinant MOMP encapsulated in PLGA 85:15 nanoparticles augments CD4
Sahu R; Dixit S; Verma R; Duncan SA; Coats MT; Giambartolomei GH; Singh SR; Dennis VA
Nanomedicine; 2020 Oct; 29():102257. PubMed ID: 32610072
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of Th1 immune response against Leishmania cysteine peptidase A, B by PLGA nanoparticle.
Noormehr H; Zavaran Hosseini A; Soudi S; Beyzay F
Int Immunopharmacol; 2018 Jun; 59():97-105. PubMed ID: 29649772
[TBL] [Abstract][Full Text] [Related]
26. Induction of a balanced Th1/Th2 immune responses by co-delivery of PLGA/ovalbumin nanospheres and CpG ODNs/PEI-SWCNT nanoparticles as TLR9 agonist in BALB/c mice.
Ebrahimian M; Hashemi M; Maleki M; Abnous K; Hashemitabar G; Ramezani M; Haghparast A
Int J Pharm; 2016 Dec; 515(1-2):708-720. PubMed ID: 27989827
[TBL] [Abstract][Full Text] [Related]
27. Carboxylated nanodiamond-mediated CRISPR-Cas9 delivery of human retinoschisis mutation into human iPSCs and mouse retina.
Yang TC; Chang CY; Yarmishyn AA; Mao YS; Yang YP; Wang ML; Hsu CC; Yang HY; Hwang DK; Chen SJ; Tsai ML; Lai YH; Tzeng Y; Chang CC; Chiou SH
Acta Biomater; 2020 Jan; 101():484-494. PubMed ID: 31672582
[TBL] [Abstract][Full Text] [Related]
28. Immune Responses to Varicella-Zoster Virus Glycoprotein E Formulated with Poly(Lactic-co-Glycolic Acid) Nanoparticles and Nucleic Acid Adjuvants in Mice.
Wang Y; Qi J; Cao H; Liu C
Virol Sin; 2021 Feb; 36(1):122-132. PubMed ID: 32757147
[TBL] [Abstract][Full Text] [Related]
29. Fabrication and characterization of Chinese yam polysaccharides PLGA nanoparticles stabilized Pickering emulsion as an efficient adjuvant.
Zhang Y; Jiao L; Wu Z; Gu P; Feng Z; Xu S; Liu Z; Yang Y; Wang D
Int J Biol Macromol; 2022 Jun; 209(Pt A):513-524. PubMed ID: 35421409
[TBL] [Abstract][Full Text] [Related]
30. Old Dog New Tricks: PLGA Microparticles as an Adjuvant for Insulin Peptide Fragment-Induced Immune Tolerance against Type 1 Diabetes.
Liu M; Feng D; Liang X; Li M; Yang J; Wang H; Pang L; Zhou Z; Yang Z; Kong D; Li C
Mol Pharm; 2020 Sep; 17(9):3513-3525. PubMed ID: 32787283
[TBL] [Abstract][Full Text] [Related]
31. Activates B lymphocytes and enhanced immune response: A promising adjuvant based on PLGA nanoparticle to improve the sensitivity of ZEN monoclonal antibody.
Pang C; Yuan B; Ren K; Xu H; Nie K; Yu C; Liu Z; Zhang Y; Ozkan SA; Yang Q
Talanta; 2024 Jul; 274():126005. PubMed ID: 38599116
[TBL] [Abstract][Full Text] [Related]
32. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS
Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572
[TBL] [Abstract][Full Text] [Related]
33. Polymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells.
Heo MB; Cho MY; Lim YT
Acta Biomater; 2014 May; 10(5):2169-76. PubMed ID: 24394635
[TBL] [Abstract][Full Text] [Related]
34. Improved vaccine-induced immune responses via a ROS-triggered nanoparticle-based antigen delivery system.
Liang X; Duan J; Li X; Zhu X; Chen Y; Wang X; Sun H; Kong D; Li C; Yang J
Nanoscale; 2018 May; 10(20):9489-9503. PubMed ID: 29675543
[TBL] [Abstract][Full Text] [Related]
35. PLGA (85:15) nanoparticle based delivery of rL7/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: A promising alternate to traditional adjuvants.
Singh D; Somani VK; Aggarwal S; Bhatnagar R
Mol Immunol; 2015 Dec; 68(2 Pt A):272-9. PubMed ID: 26442664
[TBL] [Abstract][Full Text] [Related]
36. Antigen specific immune enhancement of innate and acquired immunity by pearl in ashed form.
Elahi A; Singh MP; Ali S; Khan F
Int Immunopharmacol; 2014 Jul; 21(1):82-93. PubMed ID: 24794418
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant-active aqueous extracts from Artemisia rupestris L. improve immune responses through TLR4 signaling pathway.
Zhang A; Yang Y; Wang Y; Zhao G; Yang X; Wang D; Wang B
Vaccine; 2017 Feb; 35(7):1037-1045. PubMed ID: 28111143
[TBL] [Abstract][Full Text] [Related]
38. Cationic polymer-modified Alhagi honey polysaccharide PLGA nanoparticles as an adjuvant to induce strong and long-lasting immune responses.
Wusiman A; Jiang W; Yu L; Zhu T; He J; Liu Z; Bo R; Liu J; Wang D
Int J Biol Macromol; 2021 Apr; 177():370-382. PubMed ID: 33621572
[TBL] [Abstract][Full Text] [Related]
39. pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response.
Liu Q; Chen X; Jia J; Zhang W; Yang T; Wang L; Ma G
ACS Nano; 2015 May; 9(5):4925-38. PubMed ID: 25898266
[TBL] [Abstract][Full Text] [Related]
40. Dendritic cells support a proliferative antigen-specific T-cell response in the presence of poly(lactic-co-glycolic acid).
Srinivasan S; Elizabeth Babensee J
J Biomed Mater Res A; 2021 Nov; 109(11):2269-2279. PubMed ID: 33960123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
